“The stem cells were unable to self-renew, which resulted in long-term and irreversible impairment of tumour growth. In other words, the cancer was permanently shut down.”
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
“This is the first step toward clinically applying the principles of cancer stem cell biology to control cancer growth and advance the development of durable cures,” says principal investigator Dr. John Dick about the findings published online today in Nature Medicine.
He talks about the research in this video.
https://www.youtube.com/watch?v=QK7JquljkBc.
Dr. Dick pioneered the cancer stem cell field by first identifying leukemia stem cells (1994) and colon cancer stem cells (2007). He is also renowned for isolating a human blood stem cell in its purest form – as a single stem cell capable of regenerating the entire blood system – paving the way for clinical use (2011). Dr. Dick holds a Canada Research Chair in Stem Cell Biology and is a Senior Scientist at University Health Network’s Princess Margaret Cancer Centre and McEwen Centre for Regenerative Medicine. He is also a Professor in the Department of Molecular Genetics, University of Toronto, and Director of the Cancer Stem Cell Program at the Ontario Institute for Cancer Research.
In pre-clinical experiments, the research team replicated human colon cancer in mice to determine if specifically targeting the stem cells was clinically relevant. First, the researchers identified that the gene BMI-1, already implicated in maintaining stem cells in other cancers, is the pivotal regulator of colon cancer stem cells and drives the cycle of self-renewal, proliferation and cell survival. Next, the team used an existing small-molecule inhibitor to successfully block BMI-1, thus demonstrating the clinical relevance of this approach.
Lead author Dr. Antonija Kreso writes: “Inhibiting a recognized regulator of self-renewal is an effective approach to control tumor growth, providing strong evidence for the clinical relevance of self-renewal as a biological process for therapeutic targeting.”
Dr. Dick explains: “When we blocked the BMI-1 pathway, the stem cells were unable to self-renew, which resulted in long-term and irreversible impairment of tumour growth. In other words, the cancer was permanently shut down.”
The Latest Google Headlines on: Colon cancer
[google_news title=”” keyword=”Colon cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on: Colon cancer
- Colon Cancer and Poop: What to Watch For, According to a Colorectal Surgeonon April 17, 2024 at 10:08 pm
According to the American Cancer Society's 2024 report, colorectal cancer has surged to the forefront of health concerns, now ranking as the number one cause of cancer deaths among men under 50 and ...
- The Health of Your Mouth May Affect Your Risk of Colorectal Canceron April 17, 2024 at 7:31 pm
A bacteria found more abundantly in the mouths of people with gum disease has been linked to colorectal cancer. Regularly brushing and flossing can decrease your risk of gum disease, and therefore ...
- Liver protein could be key to preventing spread of colorectal and other cancers, CWRU researchers sayon April 17, 2024 at 4:52 pm
When secreted from the liver, the protein promotes colon cancer-cell growth. Blocking it could treat the disease.
- Colon cancer warning signs to watch out foron April 17, 2024 at 2:31 pm
Colon cancers typically start when abnormal tissues build up in the colon. That’s why doctors, like Dr. Leonard Henry, say it’s extremely important to get your screenings. He says by leaving the ...
- Presurgical Chemo May Not Improve Disease Control in Colon Canceron April 17, 2024 at 2:00 pm
There was not a significant difference between presurgical and postsurgical chemotherapy in patients with locally advanced colon cancer, researchers found.
- Health Beat: Risk factors for early-onset colorectal canceron April 17, 2024 at 1:15 pm
Last year, he had his first colonoscopy, and fortunately, the results were good. The recommended age for colorectal cancer screening is now 45. It was lowered due to an increase in cases in people ...
- Get Healthy: Communication, screening key as colon cancer increases in youngon April 17, 2024 at 6:30 am
The death of actor Chadwick Boseman, 43, who starred in “Black Panther” among other movies was stunning. It also brought to light that colorectal cancer wasn’t just a disease for ...
- Q&A: Are Black Americans Facing a Silent Crisis with Colorectal Cancer?on April 16, 2024 at 12:25 pm
Tragically, colorectal cancer has become the second leading cause of cancer death in Black Americans, and the disease is increasingly affecting younger generations, becoming the deadliest cancer among ...
- Gastrointestinal cancers: What symptoms you should look out for as colon cancer rates rise in young Canadianson April 16, 2024 at 9:09 am
Colon cancer rates are rising in young Canadians. Here's what to know about risks for different abdominal cancers, especially in light of Kate Middleton's diagnosis.
- Colon Cancer Linked to Mouth Bacteriaon April 15, 2024 at 4:29 am
Genomic research of Fusobacterium nucleatum isolated from colon cancer tumors may help researchers develop future screening tests and cancer vaccines ...
The Latest Google Headlines on: Therapeutic stem cells
[google_news title=”” keyword=”therapeutic stem cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on: Therapeutic stem cells
- SCG Cell Therapy, A*STAR enter collaboration to launch joint labs for cellular immunotherapieson April 18, 2024 at 1:28 am
GMP-compliant cell therapy production but also serve as a platform for nurturing the next generation of talent in this transformative field," said Prof Koh Boon Tong, executive director, A*STAR’s BTI.
- Buy Rating on Bioline RX Ltd for Breakthrough Stem Cell Mobilization and Enhanced Apheresis Efficiencyon April 17, 2024 at 8:05 am
Analyst Joseph Pantginis of H.C. Wainwright reiterated a Buy rating on Bioline RX Ltd Sponsored ADR (BLRX – Research Report), retaining ...
- Stem Cell Treatments for Cancer Market Size, Share, Key Players, Revenue, Demand, and Forecast to 2024 to 2032on April 16, 2024 at 5:02 pm
Report Ocean recently published a research report titled “Stem Cell Treatments for Cancer Market” 2024 Forecast to 2032 Analysis by Market Trends.” This study delivers accur ...
- 5x Classic Physique Champion Chris Bumstead Reveals the Effects of Stem Cell Therapy on His Injurieson April 16, 2024 at 8:30 am
Stem Cell therapy is all the rage among athletes, and more bodybuilders are turning to the experimental treatment. Although still not approved around the world, bodybuilders like Chris Bumstead have ...
- Somite Raises $5.3M As Five Leading Scientists Join Forces To Incorporate AI In Stem Cell Therapyon April 16, 2024 at 7:05 am
Somite, a venture-backed company aiming to become the OpenAI of stem cell biology, announces that it has raised $5.3M in pre-seed funding. The round was led by Israel's preeminent Venture fund ...
- Miraculous breakthrough: Paralyzed patient walks again with stem cell therapyon April 14, 2024 at 5:59 am
A clinical trial conducted by the Mayo Clinic, a renowned nonprofit medical research facility, has demonstrated promising results using stem cells derived from body fat to aid in the recovery of ...
- Stem Cells Newson April 10, 2024 at 5:00 pm
Feb. 7, 2024 — A tiny microfluidic device can improve cell therapy techniques for spinal cord injury patients. The device can remove a large percentage of stem cells that have not yet fully ...
- This Startup Wants To Be OpenAI Of Stem Cell Therapy, Targets $250B Marketon April 10, 2024 at 6:00 am
Somite.ai aims to improve the lives of millions of people by leveraging AI to produce human tissue for cell therapies.
- What are stem cells and how do they work in therapy?on April 9, 2024 at 10:30 pm
Stem cells offer hope in cancer treatment. India adopts regenerative therapy, focusing on personalized, targeted interventions. Pharmaceutical sector drives innovation for effective therapies.
- How to supercharge cancer-fighting cells: give them stem-cell skillson April 9, 2024 at 5:00 pm
The bioengineered immune players called CAR T cells last longer and work better if pumped up with a large dose of a protein that makes them resemble stem cells.